ACM
MDGL icon

Aster Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Aster Capital Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238K Buy
+444
New +$227K 0.05% 381
2026
Q1 		– Sell
-11
Closed -$6.41K – 1143
2025
Q4 		$6.41K Sell
11
-74
-87% -$37.8K ﹤0.01% 830
2025
Q3 		$39K Buy
+85
New +$31.7K 0.02% 545
2025
Q2 		– Sell
-2,191
Closed -$748K – 1357
2025
Q1 		$748K Buy
+2,191
New +$720K 0.14% 215

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Aster Capital Management's MDGL Position: Q2 2026 in Review

Aster Capital Management opened a new position in Madrigal Pharmaceuticals (MDGL) in Q2 2026: 444 shares worth $238K. The stake represents 0.05% of the portfolio and ranks #381 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in MDGL as recently as Q4 2025.

Aster Capital Management first reported a position in MDGL in Q1 2025 and has held it in 4 quarters since. The position peaked at $748K in Q1 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Aster Capital Management held 444 shares of Madrigal Pharmaceuticals worth $238K as of Q2 2026.
  • Madrigal Pharmaceuticals was a new Aster Capital Management position in Q2 2026.
  • Madrigal Pharmaceuticals made up 0.05% of Aster Capital Management's portfolio in Q2 2026, its #381 holding.
  • Aster Capital Management first reported a position in Madrigal Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • Aster Capital Management's Madrigal Pharmaceuticals position peaked at $748K in Q1 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.